Mesenchymal Stem Cells (MSC) Prevented the Progression of Renovascular Hypertension, Improved Renal Function and Architecture
Open Access
- 4 November 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (11), e78464
- https://doi.org/10.1371/journal.pone.0078464
Abstract
Renovascular hypertension induced by 2 Kidney-1 Clip (2K-1C) is a renin-angiotensin-system (RAS)-dependent model, leading to renal vascular rarefaction and renal failure. RAS inhibitors are not able to reduce arterial pressure (AP) and/or preserve the renal function, and thus, alternative therapies are needed. Three weeks after left renal artery occlusion, fluorescently tagged mesenchymal stem cells (MSC) (2×105 cells/animal) were injected weekly into the tail vein in 2K-1C hypertensive rats. Flow cytometry showed labeled MSC in the cortex and medulla of the clipped kidney. MSC prevented a further increase in the AP, significantly reduced proteinuria and decreased sympathetic hyperactivity in 2K-1C rats. Renal function parameters were unchanged, except for an increase in urinary volume observed in 2K-1C rats, which was not corrected by MSC. The treatment improved the morphology and decreased the fibrotic areas in the clipped kidney and also significantly reduced renal vascular rarefaction typical of 2K-1C model. Expression levels of IL-1β, TNF-α angiotensinogen, ACE, and Ang II receptor AT1 were elevated, whereas AT2 levels were decreased in the medulla of the clipped kidney. MSC normalized these expression levels. In conclusion, MSC therapy in the 2K-1C model (i) prevented the progressive increase of AP, (ii) improved renal morphology and microvascular rarefaction, (iii) reduced fibrosis, proteinuria and inflammatory cytokines, (iv) suppressed the intrarenal RAS, iv) decreased sympathetic hyperactivity in anesthetized animals and v) MSC were detected at the CNS suggesting that the cells crossed the blood-brain barrier. This therapy may be a promising strategy to treat renovascular hypertension and its renal consequences in the near future.Keywords
This publication has 34 references indexed in Scilit:
- Implantation of Mesenchymal Stem Cells Improves Right Ventricular Impairments Caused by Experimental Pulmonary HypertensionThe American Journal of the Medical Sciences, 2012
- The Potential of Stem Cells in the Treatment of Skeletal Muscle Injury and DiseaseStem Cells International, 2011
- A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem CellsTranslational Stroke Research, 2011
- Intrarenal angiotensin II and its contribution to the genesis of chronic hypertensionCurrent Opinion in Pharmacology, 2011
- Endothelial Progenitor Cells Homing and Renal Repair in Experimental Renovascular DiseaseThe International Journal of Cell Cloning, 2010
- Endothelial Progenitor Cells Restore Renal Function in Chronic Experimental Renovascular DiseaseCirculation, 2009
- Paracrine Mechanisms in Adult Stem Cell Signaling and TherapyCirculation Research, 2008
- Collecting Duct Renin Is Upregulated in Both Kidneys of 2-Kidney, 1-Clip Goldblatt Hypertensive RatsHypertension, 2008
- Cortical Microvascular Remodeling in the Stenotic KidneyArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Evidence against a role of vasopressin in the maintenance of high blood pressure in mineralocorticoid and renovascular hypertension.Hypertension, 1980